๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for pMN

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) NCT06557265Phase 1, Phase 219 sites๐Ÿ“ Little Rock๐Ÿ“ Tustin๐Ÿ“ Gainesville Nkarta, Inc. ยท Tests: NKX019, Fludarabine, Cyclophosphamide Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis. NCT07002827NA1 site๐Ÿ“ New Delhi Institute of Liver and Biliary Sciences, India ยท Tests: Darbepoetin, G-CSF, Lactulose, Albumin RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis NCT06216938EARLY Phase 11 site๐Ÿ“ Pittsburgh Yana Najjar ยท Tests: Vusolimogene oderparepvec (RP1) CHRONO-MOBILIZE: Chronotherapy of G-CSF for CD34+ Mobilization in Healthy Donors NCT07423728NA3 sites๐Ÿ“ Zhengzhou๐Ÿ“ Wuhan๐Ÿ“ Hangzhou First Affiliated Hospital of Zhejiang University ยท Tests: G-CSF (Granulocyte colony-stimulating factor) A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy NCT07096843Phase 238 sites๐Ÿ“ Denver๐Ÿ“ Orlando๐Ÿ“ Atlanta Climb Bio, Inc. ยท Tests: budoprutug A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN) NCT06962800Phase 3114 sites๐Ÿ“ Huntsville๐Ÿ“ Fresno๐Ÿ“ Los Angeles Biogen ยท Tests: Felzartamab, Tacrolimus, Standard of Care IST Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage NCT07724405Phase 21 site๐Ÿ“ Abu Dhabi Fakih IVF Fertility Center ยท Tests: Placebo control, Recombinant G-CSF Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer NCT05817214Phase 21 site๐Ÿ“ Wuhan Zhongnan Hospital ยท Tests: Cadonilimab, Anlotinib, Granulocyte-Macrophage Colony-Stimulating Factor Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS) NCT07186179n/a1 site๐Ÿ“ New Hyde Park Northwell Health ยท Tests: Mobilization Regimen OH2 Oncolytic Viral Therapy in Solid Tumors NCT03866525Phase 1, Phase 21 site๐Ÿ“ Beijing Binhui Biopharmaceutical Co., Ltd. ยท Tests: OH2 injection, with or without irinotecan or HX008 A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy NCT05696613Phase 331 sites๐Ÿ“ Los Angeles๐Ÿ“ San Dimas๐Ÿ“ Tarzana Cerium Pharmaceuticals, Inc. ยท Tests: SNP-ACTH (1-39) Gel, Rituximab Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCL NCT07749365Phase 21 site๐Ÿ“ Xiamen The First Affiliated Hospital of Xiamen University ยท Tests: hypofractionated radiotherapy plus GM-CSF, pomalidomide and glofitamab NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD) NCT05189925Phase 11 site๐Ÿ“ Bethesda National Institute of Allergy and Infectious Diseases (NIAIโ€ฆ ยท Tests: gp91 Grans Loratadine for the Prevention of G-CSF-related Bone Pain NCT05421416Phase 21 site๐Ÿ“ Edmonton AHS Cancer Control Alberta ยท Tests: Loratadine, Placebo Improving White Blood Cell Collection From Healthy Donors NCT01553214Phase 41 site๐Ÿ“ Bethesda National Institutes of Health Clinical Center (CC) ยท Tests: Filgrastim, Dexamethasone Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN) NCT07157787Phase 240 sites๐Ÿ“ Loma Linda๐Ÿ“ San Diego๐Ÿ“ Minneapolis Alexion Pharmaceuticals, Inc. ยท Tests: ALXN1920, Placebo Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors NCT07692841Phase 38 sites๐Ÿ“ Changsha๐Ÿ“ Hangzhou๐Ÿ“ Hangzhou First Affiliated Hospital of Zhejiang University ยท Tests: Single-dose Granulocyte colony-stimulating factor (G-CSF), Divided-dose Granulocyte colony-stimulating factor (G-CSF) Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy NCT05753618Phase 43 sites๐Ÿ“ Kingston๐Ÿ“ Oshawa๐Ÿ“ Ottawa Ottawa Hospital Research Institute ยท Tests: Granulocyte Colony-Stimulating Factor (G-CSF), Omission of Granulocyte Colony-Stimulating Factor (G-CSF) Study of WAL0921 in Patients With Glomerular Kidney Diseases NCT06466135Phase 250 sites๐Ÿ“ Los Angeles๐Ÿ“ Denver๐Ÿ“ Tamarac Walden Biosciences ยท Tests: WAL0921, Placebo Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN) NCT07204275Phase 2, Phase 3115 sites๐Ÿ“ Montgomery๐Ÿ“ Surprise๐Ÿ“ Los Angeles Vertex Pharmaceuticals Incorporated ยท Tests: Povetacicept, Tacrolimus A Phase 3 Study of Inebilizumab in Participants With Primary Membranous Nephropathy NCT07851220Phase 34 sites๐Ÿ“ Los Angeles๐Ÿ“ Doral๐Ÿ“ Miami Amgen ยท Tests: Inebilizumab, Tacrolimus Study of G-CSF for DOR in Patients Undergoing IVF NCT07871825Phase 41 site๐Ÿ“ New York Center for Human Reproduction ยท Tests: Neupogen 300 ฮผg subcutaneous injection, Subcutaneous injections of a saline solution A Real World Study About PMN NCT06893328n/a1 site๐Ÿ“ Guangzhou Wei Chen Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5 NCT07537400Phase 21 site๐Ÿ“ Jerusalem Shaare Zedek Medical Center ยท Tests: Naxitamab Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers NCT07300735NA1 site๐Ÿ“ Alexandria Alexandria University ยท Tests: Loratadine, Diosmin-Hesperidin, Loratadine + Diosmin-Hesperidin Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization NCT04211259EARLY Phase 12 sites๐Ÿ“ New Brunswick๐Ÿ“ New Brunswick Rutgers, The State University of New Jersey ยท Tests: Loratadine, Placebo, Questionnaire Administration Clinical Trial Protocol for the Combined Use of VAG in the Treatment of ND-AML NCT06536010NA1 site๐Ÿ“ Huai'an Yang Xiaotian ยท Tests: Venetoclax 100 mg d1๏ผŒ200 mg d2๏ผŒ400 mg d3-28๏ผ› CLAG-GO for Patients With Persistent, Relapsed or Refractory AML NCT04050280Phase 21 site๐Ÿ“ Baltimore University of Maryland, Baltimore ยท Tests: Cladribine, Cytarabine, and Granulocyte-Colony Stimulating Factor with Fractionated Gemtuzumab Ozogamicin (CLAG-GO) Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes NCT00001405n/a1 site๐Ÿ“ Bethesda National Institute of Allergy and Infectious Diseases (NIAIโ€ฆ Atacicept in Multiple Glomerular Diseases NCT06983028Phase 21 site๐Ÿ“ Brisbane Vera Therapeutics, Inc. ยท Tests: Atacicept
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy